A Convenient Synthesis of 1,4,5-Trisubstituted 1,2,3-Triazoles via 1,3-Dipolar Cycloaddition/Coupling of Alkynes, Phenylboronic Acids, and Sodium Azide Catalyzed by Cu(I)/Cu(II)

Dong Yang; Na Fu; Zenglu Liu; Ying Li; Baohua Chen

doi:10.1055/s-2007-968007

LETTER

A Convenient Synthesis of 1,4,5-Trisubstituted 1,2,3-Triazoles via 1,3-Dipolar Cycloaddition/Coupling of Alkynes, Phenylboronic Acids, and Sodium Azide Catalyzed by Cu(I)/Cu(II)

Dong Yang^a, Na Fu^a, Zenglu Liu^b, Ying Li^a, Baohua Chen*^a
^a State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, P. R. of China
^b Pharmacy College of Shanghai Jiao Tong University, Shanghai 200030, P. R. of China
Fax: +86(931)8912582; e-Mail: chbh@lzu.edu.cn;

Abstract

Alle Artikel dieser Rubrik

Abstract

A series of 1,4,5-trisubstituted 1,2,3-triazoles was prepared simply and conveniently via 1,3-dipolar cycloaddition/coupling reaction of terminal alkynes, phenylboronic acids and sodium azide in 1,4-dioxane-water using CuI/CuSO₄ as catalyst.

Key words

triazole - cycloaddition/coupling - phenylboronic acid - copper catalyst - alkyne

Volltext

Referenzen

References and Notes

<A NAME="RW19406ST-1A">1a</A> Genin MJ. Allwine DA. Anderson DJ. Barbachyn MR. Emmert DE. Garmon SA. Graber DR. Grega KC. Hester JB. Hutchinson DK. Morris J. Reischer RJ. Ford CW. Zurenko GE. Hamel JC. Schaadt RD. Stapert D. Yagi BH. J. Med. Chem. 2000, 43: 953

<A NAME="RW19406ST-1B">1b</A> Holla BS. Mahalinga M. Karthikeyan MS. Poojary B. Akberali PM. Kumari NS. Eur. J. Med. Chem. 2005, 40: 1173

<A NAME="RW19406ST-1C">1c</A> Tian L. Sun Y. Li H. Zheng X. Cheng Y. Liu X. Qian B. J. Inorg. Biochem. 2005, 99: 1646

<A NAME="RW19406ST-2A">2a</A> Buckle DR. Outred DJ. Rockell CJM. Smith H. Spicer BA. J. Med. Chem. 1983, 26: 251

<A NAME="RW19406ST-2B">2b</A> Buckle DR. Rockell CJM. Smith H. Spicer BA. J. Med. Chem. 1986, 29: 2262

<A NAME="RW19406ST-3">3</A> Alvarez R. Velázquez S. San-Felix A. Aquaro S. De Clercq E. Perno C.-F. Karlsson A. Balzarini J. Camarasa MJ. J. Med. Chem. 1994, 37: 4185

<A NAME="RW19406ST-4">4</A> Al-Masoudi NA. Al-Soud YA. Tetrahedron Lett. 2002, 43: 4021

<A NAME="RW19406ST-5">5</A> Wamhoff H. In Comprehensive Heterocyclic Chemistry Vol. 5: Katritzky AR. Rees CW. Pergamon; Oxford: 1984. p.669

<A NAME="RW19406ST-6A">6a</A> L’Abbé G. Chem. Rev. 1969, 69: 345

<A NAME="RW19406ST-6B">6b</A> Huisgen R. In 1,3-Dipolar Cycloaddition Chemistry Padwa A. Wiley; New York: 1984. Chap. 1. p.1

<A NAME="RW19406ST-6C">6c</A> Abu-Orabi ST. Molecules 2002, 7: 302

<A NAME="RW19406ST-6D">6d</A> Katritzky AR. Singh SK. J. Org. Chem. 2002, 67: 9077

<A NAME="RW19406ST-6E">6e</A> Katritzky AR. Zhang Y. Singh SK. Heterocycles 2003, 60: 1225

<A NAME="RW19406ST-7A">7a</A> Rostovtsev VV. Green LG. Fokin VV. Sharpless KB. Angew. Chem. Int. Ed. 2002, 41: 2596

<A NAME="RW19406ST-7B">7b</A> Chan TR. Hilgraf R. Sharpless KB. Fokin VV. Org. Lett. 2004, 6: 2853

<A NAME="RW19406ST-7C">7c</A> Orgueira HA. Fokas D. Isome Y. Chan PCM. Baldino CM. Tetrahedron Lett. 2005, 46: 2911

<A NAME="RW19406ST-7D">7d</A> Pachon LD. Van Maarseveen JH. Rothenberg G. Adv. Synth. Catal. 2005, 347: 811

<A NAME="RW19406ST-7E">7e</A> Appukkuttan P. Dehaen W. Fokin VV. Eycken EV. Org. Lett. 2004, 6: 4223

<A NAME="RW19406ST-8">8</A> Krasinski A. Fokin VV. Sharpless KB. Org. Lett. 2004, 6: 1237

<A NAME="RW19406ST-9">9</A> Kamijo S. Jin T. Huo Z. Yamamoto Y. Tetrahedron Lett. 2002, 43: 9707

<A NAME="RW19406ST-10">10</A> Kamijo S. Jin T. Huo Z. Yamamoto Y. J. Am. Chem. Soc. 2003, 125: 7786

<A NAME="RW19406ST-11">11</A> Gerard B. Ryan J. Beeler AB. Porco JA. Tetrahedron 2006, 62: 6405

<A NAME="RW19406ST-12">12</A> Scriven EFV. Turnbull K. Chem. Rev. 1988, 88: 297

<A NAME="RW19406ST-13">13</A> Kolb HC. Sharpless KB. Drug Discovery Today 2003, 8: 1128

<A NAME="RW19406ST-14">14</A> Feldman AK. Colasson B. Fokin VV. Org. Lett. 2004, 6: 3897

<A NAME="RW19406ST-15A">15a</A> Ainley AD. Challenger F. J. Chem. Soc. 1930, 2171

<A NAME="RW19406ST-15B">15b</A> Thiebes C. Prakash GKS. Petasis NA. Olah GA. Synlett 1998, 141

Synthesis of 4-(4-Methoxyphenyl)-5-[2-(4-methoxy-phenyl)ethynyl]-1-phenyl-1 H -1,2,3-triazole ( 4a); Typical Procedure: A mixture of 1a (50.0 mg, 0.41 mmol), 2a (118.9 mg, 0.90 mmol), sodium azide (3; 40.3 mg, 0.62 mmol), CuI (7.8 mg, 0.041 mmol) and CuSO₄·5H₂O (20.5 mg, 0.082 mmol) in 1,4-dioxane (10 mL) and H₂O (5 mL) was stirred overnight. Then, the reaction mixture was diluted with H₂O (20 mL) and was extracted with CH₂Cl₂ (3 × 20 mL). The combined organic extracts were dried over MgSO₄, filtered and concentrated. The residue was purified by column chromatography (PE-EtOAc, 10:1) to afford 4a (98.5 mg, 63%) as a white solid; mp 86-88 °C. IR (KBr): 2216 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 3.83 (s, 3 H), 3.87 (s, 3 H), 6.89 (d, J = 9.3 Hz, 2 H), 7.03 (d, J = 8.7 Hz, 2 H), 7.40 (d, J = 8.7 Hz, 2 H), 7.50-7.60 (m, 3 H), 7.88 (d, J = 8.1 Hz, 2 H), 8.21 (d, J = 9.3 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 55.3 (CH₃), 55.4 (CH₃), 75.4 (C), 102.0 (C), 113.6 (C), 114.1 (CH), 114.3 (CH), 116.3 (C), 122.9 (C), 123.7 (CH), 127.8 (CH), 129.2 (CH), 129.7 (CH), 133.0 (CH), 136.7 (C), 148.1 (C), 160.0 (C), 160.6 (C). EI-MS: m/z = 381 [M⁺], 353 [M - N₂]⁺. Anal. Calcd for C₂₄H₁₉N₃O₂: C, 75.57; H, 5.02; N, 11.02. Found: C, 75.50; H, 4.99; N, 10.98.
1,4-Diphenyl-5-(2-phenylethynyl)-1 H -1,2,3-triazole ( 4b): white solid; mp 105-107 °C. IR (KBr): 2215 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 7.38-7.60 (m, 11 H), 7.88 (d, J = 8.4 Hz, 2 H), 8.28 (d, J = 7.5 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 76.4 (C), 102.0 (C), 116.8 (C), 121.4 (C), 123.8 (CH), 126.5 (CH), 128.6 (CH), 128.7 (CH), 128.7 (CH), 129.2 (CH), 129.4 (CH), 129.6 (CH), 130.1 (C), 131.4 (CH), 136.5 (C), 148.5 (C). EI-MS: m/z = 321 [M⁺], 293 [M -N₂]⁺. Anal. Calcd for C₂₂H₁₅N₃: C, 82.22; H, 4.70; N, 13.08. Found: C, 82.16; H, 4.71; N, 13.04.
5-(Hept-1-ynyl)-4-pentyl-1-phenyl-1 H -1,2,3-triazole ( 4c): liquid. IR (KBr): 2236 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 0.87-0.94 (m, 6 H), 1.26-1.42 (m, 8 H), 1.53-1.60 (m, 2 H), 1.76-1.81 (m, 2 H), 2.45 (t, J = 7.0 Hz, 2 H), 2.79 (t, J = 7.6 Hz, 2 H), 7.44-7.53 (m, 3 H), 7.78 (d, J = 6.9 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 13.87 (CH₃), 13.94 (CH₃), 19.6 (CH₂), 22.1 (CH₂), 22.3 (CH₂), 25.4 (CH₂), 27.7 (CH₂), 28.5 (CH₂), 30.9 (CH₂), 31.4 (CH₂), 66.9 (C), 103.1 (C), 118.7 (C), 123.3 (CH), 128.8 (CH), 129.0 (CH), 136.8 (C), 151.2 (C). EI-MS: m/z = 309 [M⁺], 281 [M - N₂]⁺. Anal. Calcd for C₂₀H₂₇N₃: C, 77.63; H, 8.79; N, 13.58. Found: C, 77.56; H, 8.77; N, 13.55.
1-(4-Chlorophenyl)-4-(4-methoxyphenyl)-5-[2-(4-methoxyphenyl)ethynyl]-1 H -1,2,3-triazole ( 4d): white solid; mp 150-152 °C. IR (KBr): 2214 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 3.84 (s, 3 H), 3.87 (s, 3 H), 6.91 (d, J = 9.0 Hz, 2 H), 7.02 (d, J = 8.7 Hz, 2 H), 7.41 (d, J = 9.0 Hz, 2 H), 7.54 (d, J = 8.7 Hz, 2 H), 7.84 (d, J = 9.0 Hz, 2 H), 8.20 (d, J = 9.3 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 55.3 (CH₃), 55.4 (CH₃), 75.2 (C), 102.4 (C), 113.3 (C), 114.1 (CH), 114.4 (CH), 116.2 (C), 122.7 (C), 124.8 (CH), 127.8 (CH), 129.4 (CH), 133.1 (CH), 135.1 (C), 135.2 (C), 148.3 (C), 160.0 (C), 160.7 (C). EI-MS: m/z = 415 [M⁺], 387 [M - N₂]⁺. Anal. Calcd for C₂₄H₁₈ClN₃O₂: C, 69.31; H, 4.36; N, 10.10. Found: C, 69.27; H, 4.32; N, 10.08.
1-(4-Chlorophenyl)-4-phenyl-5-(2-phenylethynyl)-1 H -1,2,3-triazole ( 4e): white solid; mp 95-97 °C. IR (KBr): 2219 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 7.39-7.57 (m, 10 H), 7.85 (d, J = 8.1 Hz, 2 H), 8.26 (d, J = 8.4 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 76.1 (C), 102.4 (C), 116.7 (C), 121.2 (C), 124.9 (CH), 126.5 (CH), 128.7 (CH), 128.7 (CH), 128.9 (CH), 129.5 (CH), 129.8 (CH), 129.9 (C), 131.5 (CH), 135.0 (C), 135.3 (C), 148.7 (C). EI-MS: m/z = 355 [M⁺], 327 [M - N₂]⁺. Anal. Calcd for C₂₂H₁₄ClN₃: C, 74.26; H, 3.97; N, 11.81. Found: C, 74.21; H, 3.96; N, 11.77.
1-(4-Acetylphenyl)-4-(4-methoxyphenyl)-5-[2-(4-methoxyphenyl)ethynyl]-1 H -1,2,3-triazole ( 4f): white solid; mp 126-128 °C. IR (KBr): 2214, 1685 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 2.67 (s, 3 H), 3.84 (s, 3 H), 3.87 (s, 3 H), 6.91 (d, J = 8.4 Hz, 2 H), 7.03 (d, J = 8.4 Hz, 2 H), 7.43 (d, J = 8.1 Hz, 2 H), 8.06 (d, J = 8.4 Hz, 2 H), 8.16 (d, J = 8.1 Hz, 2 H), 8.20 (d, J = 8.1 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 26.7 (CH₃), 55.3 (CH₃), 55.4 (CH₃), 75.2 (C), 102.7 (C), 113.2 (C), 114.1 (CH), 114.4 (CH), 116.0 (C), 122.5 (C), 123.2 (CH), 127.8 (CH), 129.4 (CH), 133.0 (CH), 137.0 (C), 140.0 (C), 148.5 (C), 160.1 (C), 160.8 (C), 196.8 (C). EI-MS: m/z = 423 [M⁺], 395 [M -N₂]⁺. Anal. Calcd for C₂₆H₂₁N₃O₃: C, 73.74; H, 5.00; N, 9.92. Found: C, 73.71; H, 5.02; N, 9.89.
1-(4-Acetylphenyl)-4-phenyl-5-(2-phenylethynyl)-1 H -1,2,3-triazole ( 4g): white solid; mp 138-140 °C. IR (KBr): 2215, 1680 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 2.69 (s, 3 H), 7.41-7.55 (m, 8 H), 8.08 (d, J = 8.7 Hz, 2 H), 8.18 (d, J = 9.0 Hz, 2 H), 8.28 (d, J = 7.8 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 26.7 (CH₃), 76.1 (C), 102.7 (C), 108.3 (C), 121.2 (C), 123.4 (CH), 126.6 (CH), 128.73 (CH), 128.77 (CH), 129.0 (CH), 129.5 (CH), 129.83 (C), 129.91 (CH), 131.5 (CH), 137.3 (C), 139.9 (C), 149.1 (C), 196.8 (C). EI-MS: m/z = 363 [M⁺], 335 [M - N₂]⁺. Anal. Calcd for C₂₄H₁₇N₃O: C, 79.32; H, 4.72; N, 11.56. Found: C, 79.30; H, 4.69; N, 11.51.
1-(4-Acetylphenyl)-4-pentyl-5-(hept-1-ynyl)-1 H -1,2,3-triazole ( 4h): liquid. IR (KBr): 2235, 1689 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 0.88-0.93 (m, 6 H), 1.31-1.39 (m, 8 H), 1.57-1.64 (m, 2 H), 1.76-1.81 (m, 2 H), 2.49 (t, J = 6.8 Hz, 2 H), 2.67 (s, 3 H), 2.79 (t, J = 7.5 Hz, 2 H), 7.98 (d, J = 8.7 Hz, 2 H), 8.11 (d, J = 8.1 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 13.88 (CH₃), 13.94 (CH₃), 19.6 (CH₂), 22.1 (CH₂), 22.3 (CH₂), 25.3 (CH₂), 26.6 (CH₃), 27.7 (CH₂), 28.5 (CH₂), 31.0 (CH₂), 31.3 (CH₂), 66.7 (C), 104.0 (C), 118.6 (C), 122.8 (CH), 129.3 (CH), 136.8 (C), 140.3 (C), 151.8 (C), 196.8 (C). EI-MS: m/z = 351 [M⁺], 323 [M - N₂]⁺. Anal. Calcd for C₂₂H₂₉N₃O: C, 75.18; H, 8.32; N, 11.96. Found: C, 75.11; H, 8.33; N, 11.93.
1-(2-Methoxyphenyl)-4-(4-methoxyphenyl)-5-[2-(4-methoxyphenyl)ethynyl]-1 H -1,2,3-triazole ( 4i): white solid; mp 96-98 °C. IR (KBr): 2217 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 3.81 (s, 3 H), 3.84 (s, 3 H), 3.87 (s, 3 H), 6.84 (d, J = 8.7 Hz, 2 H), 7.02 (d, J = 8.7 Hz, 2 H), 7.12 (t, J = 7.5 Hz, 2 H), 7.28 (d, J = 9.3 Hz, 2 H), 7.50 (d, J = 7.2 Hz, 2 H), 8.22 (d, J = 9.0 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 55.3 (CH₃), 55.3 (CH₃), 55.9 (CH₃), 75.1 (C), 101.0 (C), 112.2 (CH), 113.8 (C), 114.0 (CH), 114.2 (CH), 118.9 (C), 120.6 (CH), 123.2 (C), 125.4 (C), 127.6 (CH), 128.3 (CH), 131.5 (CH), 133.0 (CH), 146.8 (C), 154.3 (C), 159.8 (C), 160.3 (C). EI-MS: m/z = 411 [M⁺], 383 [M - N₂]⁺. Anal. Calcd for C₂₅H₂₁N₃O₃: C, 72.98; H, 5.14; N, 10.21. Found: C, 72.93; H, 5.10; N, 10.20.
1-(2-Methoxyphenyl)-4-phenyl-5-(2-phenylethynyl)-1 H -1,2,3-triazole ( 4j): white solid; mp 84-86 °C. IR (KBr): 2219 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 3.83 (s, 3 H), 7.10-7.52 (m, 12 H), 8.30 (d, J = 8.4 Hz, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 55.8 (CH₃), 76.1 (C), 101.0 (C), 112.1 (CH), 119.4 (C), 120.6 (CH), 121.6 (C), 125.1 (C), 125.8 (CH), 126.3 (CH), 128.2 (CH), 128.5 (CH), 128.6 (CH), 129.3 (CH), 130.3 (C), 131.3 (CH), 131.7 (CH), 147.1 (C), 154.2 (C). EI-MS: m/z = 351 [M⁺], 323 [M - N₂]⁺. Anal. Calcd for C₂₃H₁₇N₃O: C, 78.61; H, 4.88; N, 11.96. Found: C, 78.55; H, 4.91; N, 11.94.

<A NAME="RW19406ST-17A">17a</A> Siemsen P. Livingston RC. Diederich F. Angew. Chem. Int. Ed. 2000, 39: 2632

<A NAME="RW19406ST-17B">17b</A> Myers AG. Goldberg SD. Angew Chem. Int. Ed. 2000, 39: 2732

Crystal data: C₂₂H₁₅N₃, MW = 321.37, T = 294(2) K, λ = 0.71073 Å, monoclinic, space group P2₁/c, a = 7.6038(2) Å, b = 18.6814(6) Å, c = 12.1815(4) Å, α = 90.00°, β = 91.356 (2)°, γ = 90.00°, V = 1729.89(9) Å³, Z = 4, D = 1.234 g/cm³, µ = 0.074 mm^-1, F(000) = 672.0. Crystallographic data (excluding structure factors) for the structure reported in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication CCDC-626008.